- Home
- PNFP vs HALO Comparison
PNFP vs HALO Comparison
Compare PNFP & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNFP
- HALO
- Stock Information
- Founded
- PNFP 2000
- HALO 1998
- Country
- PNFP United States
- HALO United States
- Employees
- PNFP N/A
- HALO N/A
- Industry
- PNFP Major Banks
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PNFP Finance
- HALO Health Care
- Exchange
- PNFP Nasdaq
- HALO Nasdaq
- Market Cap
- PNFP 7.0B
- HALO 7.6B
- IPO Year
- PNFP N/A
- HALO N/A
- Fundamental
- Price
- PNFP $96.19
- HALO $71.82
- Analyst Decision
- PNFP Buy
- HALO Buy
- Analyst Count
- PNFP 12
- HALO 8
- Target Price
- PNFP $118.83
- HALO $70.25
- AVG Volume (30 Days)
- PNFP 1.7M
- HALO 2.2M
- Earning Date
- PNFP 10-14-2025
- HALO 08-05-2025
- Dividend Yield
- PNFP 1.00%
- HALO N/A
- EPS Growth
- PNFP 48.26
- HALO 68.93
- EPS
- PNFP 7.51
- HALO 4.37
- Revenue
- PNFP $1,812,787,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- PNFP $29.69
- HALO $25.38
- Revenue Next Year
- PNFP $11.74
- HALO $20.19
- P/E Ratio
- PNFP $12.82
- HALO $16.44
- Revenue Growth
- PNFP 21.56
- HALO 34.97
- 52 Week Low
- PNFP $81.57
- HALO $42.01
- 52 Week High
- PNFP $131.91
- HALO $72.33
- Technical
- Relative Strength Index (RSI)
- PNFP 50.16
- HALO 86.58
- Support Level
- PNFP $91.81
- HALO $61.27
- Resistance Level
- PNFP $94.25
- HALO $72.33
- Average True Range (ATR)
- PNFP 2.39
- HALO 1.69
- MACD
- PNFP 1.19
- HALO 0.77
- Stochastic Oscillator
- PNFP 91.51
- HALO 96.06
About PNFP Pinnacle Financial Partners Inc.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.